A pilot randomised controlled trial of physical activity facilitation for older adults:feasibility study findings by Morgan, Gemma et al.
                          Morgan, G., Haase, A., Campbell, R., & Ben-Shlomo, Y. (2019). A pilot
randomised controlled trial of physical activity facilitation for older adults:
feasibility study findings. Pilot and Feasibility Studies, 5, [40].
https://doi.org/10.1186/s40814-019-0414-9
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s40814-019-0414-9
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Frontiers at
https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-019-0414-9 . Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
RESEARCH Open Access
A pilot randomised controlled trial of
physical activity facilitation for older adults:
feasibility study findings
Gemma S. Morgan1* , Anne M. Haase2, Rona M. Campbell1 and Yoav Ben-Shlomo1
Abstract
Background: More people are living longer lives leading to a growth in the population of older adults, many of
whom have comorbidities and low levels of physical function. Physical activity in later life can prevent or delay age-
related disability. Identifying a cost-effective means of increasing physical activity in older adults therefore remains
an important public health priority.
Physical Activity Facilitation (PAF) is an intervention shown to increase physical activity in adults with depression.
The PAF model was modified for a population of older adults at risk of disability. This study aimed to assess the
feasibility of undertaking a definitive RCT of the PAF intervention in the target population.
Methods: A pilot randomised controlled trial (RCT) was delivered through primary care. Patients at risk of disability and
who were not meeting recommended levels of physical activity were recruited through postal invitation and direct
approach in the practice waiting room. Those meeting eligibility criteria were enrolled and randomised at a 2:1 ratio
to the PAF intervention and control. Behaviour change techniques were used by facilitators with participants over the
telephone and face-to-face for 6months. Outcome measures including physical function, physical activity, depression,
social support, and quality of life were collected at baseline and at 6months.
Results: A high proportion of patients responded to the initial invitation (68%), yet many were ineligible due to high
levels of self-reported physical activity and baseline physical function. Fifty-one participants were recruited to the trial,
with an average age of 74 years (range 65–89), and there were high rates of adherence and retention to the study (94%
follow-up at 6months). The majority of outcome data collected from participants was complete; however, the validated
scale used to measure self-reported physical activity was associated with high levels of missing data.
Conclusions: The findings of this pilot RCT suggest that it is feasible to deliver a definitive RCT of the PAF intervention
in this population. Further work is required to improve the efficiency of recruitment and to minimise missing data from
self-reported physical activity measures.
Trial registration: Current controlled trials ISRCTN80470273. Registered 25 October 2013.
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Background
Recent advances in medical science and public health
have reduced overall premature mortality, resulting in a
larger population of older adults with increasing preva-
lence of comorbidities. In the UK in 2016, adults aged
65 years and over comprised 18% of the population and
it is projected that this will increase to 25% over the next
30 years [1]. It is therefore important that we identify
ways of enabling older people to function well and live
independently as they age. Findings from the LIFE study
[2] support the hypothesis that physical activity in later
life can prevent or delay age-related disability. However,
we know that only around half of 65–74 year olds in the
UK report doing sufficient activity to meet recom-
mended targets [3, 4] and physical activity levels in those
aged 75 years and older are even lower [5]. Identifying a
cost-effective and sustainable means of increasing phys-
ical activity in older adults therefore remains an import-
ant public health priority.
An existing intervention, Physical Activity Facilitation
[6], has been used successfully to increase physical activ-
ity in adults with depression [7]. The PAF intervention
was modified and developed for application to a popula-
tion of older adults at risk of disability. The intervention
uses facilitators to deliver behaviour change techniques
with motivational interviewing strategies [8]. In sum-
mary, the PAF facilitator acts as the main agent of
change and aims to address the core psychological needs
of participants through face-to-face and telephone
sessions. It is hypothesised that the PAF intervention will
be effective in increasing physical activity in older adults
at risk of disability, and that the increased physical
activity will lead to a reduction in disability and/or
improved physical performance.
Aim and objectives
The aim of this study was to assess the feasibility of
undertaking a definitive and full-scale RCT of the PAF
intervention in the target population. There were four
objectives linked to the pilot RCT:
i) Test the effectiveness of methods of recruitment
and enrolment
ii) Assess retention and adherence to the study and/or
intervention
iii) Evaluate the methods of data collection and analysis
for a definitive trial
iv) Provide estimates of the variability of key outcomes
to enable estimation of the sample size and
resources required for a future definitive trial
A series of criteria, indicating what needed to be
achieved in the pilot and feasibility for there to be
progression to a definitive trial, were prespecified (see
Table 1). In addition, a mixed methods process evalu-
ation was nested within the pilot RCT to assess imple-
mentation and acceptability including adverse events,
mechanism of impact, and context. Detailed methods
and findings from the process evaluation will be pub-
lished separately.
Methods
The study protocol has been published previously [9];
methods for the pilot trial are summarised below.
Recruitment and randomisation
The initial recruitment target was 60 adults aged 65
years and over from six primary care practices based in
areas of differing social deprivation across the South
West area. This sample size was a pragmatic decision to
ensure that adequate participants were available to esti-
mate the key parameters [10]; recruitment closed at 51
participants. Recruitment ran for 9 months from April
2014 to January 2015 using a combination of postal
invitation and opportunistic recruitment of patients
from the practice waiting room.
Recruitment by postal invitation
Practice staff identified an initial list of patients, ran-
domly selecting a sample of those aged 65 and older and
using “read codes” (codes used in electronic records to
categorise patients and consultations) to exclude those
with medical conditions listed in the exclusion criteria
(see Table 2 for full eligibility criteria). General practi-
tioners (GPs) reviewed the lists, and the final sample of
patients was sent recruitment materials in the post. A
single reminder invitation was sent to non-responders.
Subjects expressing an interest in the study were
followed up with a brief telephone screening call, and
those reporting eligibility against broad criteria were
invited to a screening clinic for full eligibility assessment
(see Additional file 1: Figure S1 for details of questions
asked during telephone screening).
Recruitment in the waiting room
A large poster and leaflets in the practice informed pa-
tients that a researcher was present and recruiting for a
study. Patients who appeared to broadly fit the eligibil-
ity criteria, as mentioned above, were approached, and
those agreeing to speak with the researcher were asked
the same broad eligibility questions asked during
telephone screening (see Additional file 1: Figure S1).
Individuals meeting the eligibility criteria were provided
with a brief explanation of the study and an informa-
tion leaflet. Those providing contact details at the time
were called a few days later to arrange a screening
clinic appointment for full eligibility assessment, and
those expressing an interest but not happy to provide
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contact details were given a reply slip to return to the
study team.
Screening
As the PAF intervention has been designed as a prevent-
ive intervention, the target population were those who
were non-disabled at baseline, but who were at risk of
developing disability. As detailed in Table 2, to be eli-
gible, participants were required (1) to be walking inde-
pendently at baseline and (2) to have a level of
functional performance that indicated an increased risk
of disability. At the screening clinic, potential partici-
pants were screened for these two criteria.
Walking independently at baseline
There is evidence that the ability to complete a 4-m
walking test (4MWT) at usual pace at a speed of 0.8 m/s
or greater is highly predictive [11] of successfully com-
pleting the commonly used 400-m walk test (400MWT)
[12] which is valid [11] and reliable [2]. Due to space
limitations, the 4MWT was used as an alternative to the
400MWT and 0.8 m/s was used as the minimal thresh-
old to be deemed walking independently at baseline. It
was observed that a significant proportion of potential
participants spent time “warming up” from a stationary
position. As it was not specified whether the 4-m meas-
urement should be taken from a standing start or from a
mid-stride position, we included a short (1–2 m)
“run-up” before the stopwatch was started. Times were
recorded to the nearest hundredth of a second.
Assessing risk of mobility disability in the future
The Short Physical Performance Battery (SPPB) assesses
elements of lower limb function and is a composite
measure of walking speed (along a 4-m track), chair
rises, and balance. The summary scores range from 1
(indicating lowest performance) to 12 (highest perform-
ance). The SPPB has been shown to be reliable [13], as-
sociated with disability-related outcomes including
nursing home admission [14], and predictive of future
new-onset disability, both self-reported and objective
[15]. A systematic review of the predictive value of the
SPPB concluded that individuals scoring less than 10 out
of 12 have up to a 5-fold increased risk of new-onset dis-
ability [16]; this was used as the threshold for inclusion
in the pilot RCT.
Confirming exclusion criteria
Participants were asked to confirm the absence of each
exclusion criterion listed in Table 2 before enrolment;
Table 1 Pre-specified feasibility criteria
Criteria for proceeding to definitive trial Assessment Linked objective
An acceptable proportion of individuals
respond to recruitment invitations.
Recruitment records show an initial response rate of
> 10% to postal invitation and/or > 25% to primary
care practitioner invitation or waiting room
recruitment. The three methods will be compared.
(1) Test the effectiveness of methods of recruitment
and enrolment
An acceptable proportion of individuals
responding to recruitment invitations
are eligible to participate.
Screening records show a screen-failure rate
of < 80%.
(1) Test the effectiveness of methods of recruitment
and enrolment
Attrition from the pilot trial is low. Trial records show that the proportion of enrolled
participants “lost to follow-up” at 6 months is < 20%,
excluding deaths and long-term care or
hospitalisation.
(2) Assess retention and adherence to the study
and/or intervention
PAF intervention attracts high rates of
participation from eligible adults.
Trial records indicate that adherence to the
intervention is high; ≥ 65% of intervention
participants participate in at least one face-to-face
and five telephone sessions.
(2) Assess retention and adherence to the study
and/or intervention
PAF can engage individuals from a
range of socio-economic localities.
Participants are recruited from primary care practices
in wards with high deprivation scores and low
deprivation scores.
(1) Test the effectiveness of methods of recruitment
and enrolment
PAF delivery costs can be recorded in a
way that enables cost-effectiveness
analysis.
Systems developed in the exploratory trial can be
used to monitor the costs of a definitive RCT.
(3) Evaluate the methods of data collection and
analysis for a definitive trial
Methods for measuring primary and
secondary outcomes and mediator
variables are feasible and acceptable.
Process evaluation findings and completed
questionnaires suggest that self-report and objective
measures were comprehensible and acceptable to
> 80% of participants.
(3) Evaluate the methods of data collection and
analysis for a definitive trial
The sample size required for an
adequately powered trial is achievable.
Measurement variability of the primary outcome,
recruitment rates, and expected attrition are
consistent with a sample size that can be achieved
within a reasonable time.
(4) Provide estimates of the variability of key
outcomes to enable estimation of the sample size
and resources required for a future definitive trial
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these were subsequently corroborated with each partici-
pant’s GP. Eligible participants who provided consent to
enrol in the study completed further baseline assess-
ments (physical assessments and paper-based surveys)
and were randomly allocated, using a computer-based
randomisation system, to either the PAF intervention or
usual care at a 2:1 ratio. The 2:1 ratio was chosen to
ensure adequate numbers of intervention participants
remained in the study in order to ensure rich data
collection in the process evaluation. This approach is an
accepted method of ensuring adequate retention in the
intervention arm [17]. To ensure similar distribution of
participant characteristics between each arm, a mini-
misation algorithm was used, minimising on age, gender,
and GP practice.
Intervention and control arms
The PAF intervention is based upon self-determination
theory [18], which asserts that for an individual to mod-
ify their behaviour, three core psychological needs must
be met: the need for autonomy (having control and
choice over activity), for competence (feeling capable
about doing something), and for relatedness (feeling
connected to and supported by others). Evidence-based
behaviour change techniques [19] derived from control
theory such as action planning, goal setting, self-moni-
toring of behaviour, feedback, and goal reviewing were
used during sessions, and where possible, the PAF facili-
tators aimed to focus on “lifestyle physical activity”, i.e.
that which fits into an individual’s day-to-day life and
daily routine. Each participant randomised to the inter-
vention was offered an initial face-to-face PAF session,
up to two further face-to-face sessions, and up to nine
telephone support sessions over the 6-month
intervention period. Sessions were not at fixed intervals
but were tailored to suit the individual participant and
their progress. Worksheets designed to assist with
behaviour change techniques were available for facilita-
tors and participants to use. PAF facilitators were re-
cruited locally; previous experience working with older
adults or in health or social care was desirable but not
essential. A 3-day training course and comprehensive
training manual were provided at the start of the study,
and regular supervision was provided throughout the
intervention period.
Participants randomised to the control arm were
provided with a booklet which contained advice on
healthy ageing and which was publicly available,
published by a national voluntary organisation.
Study outcomes
The primary quantitative outcomes were measures of
feasibility to inform the design of a future full-scale trial,
i.e. effectiveness of recruitment strategies, measures of re-
tention and adherence, and the feasibility of collecting
outcome measures. It is not appropriate to conduct
hypothesis testing around effectiveness in an underpow-
ered pilot study. However, the methods used for evaluat-
ing the intervention in a definitive trial were replicated in
this pilot study, as a means of testing the feasibility of data
collection and analysis and to identify the standard devi-
ation of key variables, which may be used as primary
outcomes in powering a future definitive trial. Variables
most likely to be considered as a primary outcome in a de-
finitive trial include mean walking speed; SPPB score; and
daily minutes of light, moderate-to-vigorous, and seden-
tary activity. Walking speed and performance on the SPPB
were measured as part of the screening clinic and were
Table 2 Participant eligibility criteria
Inclusion
criteria
• Aged 65 years or older
• Living in the community; this includes those living in sheltered accommodation
• Not meeting recommended levels of physical activity, defined as less than 150min of moderate, or 75 min of vigorous, physical
activity per week
• Not disabled at baseline, defined using a walking speed of at least 0.8 m/s along a 4-m walk track.
• At risk of subsequent disability, defined as a score of less than 10 out of 12 on the SPPB
Exclusion
criteria
• Unable to participate in the intervention or study due to speech, language, or sensory problems
• Resident in a nursing home
• Intention to move out of the study area within 6 m of the screening clinic visit or to be away for more than 8 consecutive weeks
during this period
• Concurrent participation in an “exercise-on-prescription” or a physical rehabilitation programme or study
• A documented or patient-reported medical condition including but not limited to severe, uncontrolled arthritis; severe lung dis
ease requiring regular use of corticosteroids or supplemental oxygen; serious cardiovascular disease; history of cardiac arrest;
neuromuscular or musculoskeletal conditions exacerbated by exercise; moderate or severe cognitive impairment or dementia;
severe uncontrolled psychiatric illness; and multiple (≥ 2) falls in previous 3 months
• Investigator concern about an individual’s safety or ability to adhere to the intervention if enrolled in the trial
m/s metres per second, SPPB Short Physical Performance Battery
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repeated by a trained nurse or healthcare assistant, who
was blinded to the treatment allocation, at a follow-up
clinic held 6months after enrolment. Measures of object-
ive physical activity were collected using an Actigraph
GT1M accelerometer which participants wore on a waist-
band for 7 days immediately after enrolment and for 7
days immediately before the follow-up clinic at 6months.
Only when there were five or more valid wear days (when
the accelerometer detected it was being worn for at least
10 h) were the data used in analysis. Accelerometer
non-wear time was defined as a run of 60min of consecu-
tive zero counts, consistent with other studies on older
adults [20], allowing for a 2-min interruption, and the
spurious value detection was set at 20,000 counts, based
on 60-s epochs. Sociodemographic data were collected on
housing tenure, marital status, and social class (including
years of full-time, continuous education), in addition to
smoking status and alcohol intake as lifestyle variables.
Variables likely to be secondary outcomes of interest in a
definitive trial were explored at baseline and 6-month
follow-up and included grip strength measured using the
Jamar Hydraulic Hand Dynamometer and NIH measure-
ment protocol [21], depression measured as a continuous
variable by summing scores on the 15-point Geriatric De-
pression Scale (GDS) [22], self-reported physical activity
using the Physical Activity Scale for the Elderly (PASE)
questionnaire [23], cognitive performance using the Mon-
treal Cognitive Assessment (MoCA) [24], BMI, self-re-
ported disability using Lawton’s Instrumental Activities of
Daily Living (IADL) [25], social support using items from
the National Health and Nutrition Examination Survey,
and self-reported number of daily trips made outside of
the home, collected using a journey log in conjunction
with the accelerometer. For the feasibility assessment of
an economic evaluation, quality of life was measured using
EQ5D and ICECAP-O [26–28]. Data on healthcare use
were obtained by reviewing GP records for all GP
face-to-face consultations, out-patient appointments,
hospital admissions, and emergency appointments in the
12months prior to the start of the study. Follow-up data
on healthcare use were obtained by reviewing GP records
for the same events in the period following the follow-up
clinic appointment. At the end of the follow-up clinic,
participants were given a gift voucher worth £15 as a
token of gratitude for their contribution to the study.
Statistical analyses
Hypothesis testing for differences between two groups
was undertaken using unpaired t tests to compare
numerical means of continuous data, and chi-squared
tests for categorical data, unless the expected value in a
cell was less than five, in which case Fisher’s exact test
was performed. Analysis of multi-group data was
conducted using chi-squared tests for categorical data
and one-way analysis of variance (ANOVA) for continu-
ous data to test for heterogeneity. The distributions of
all variables were inspected using histograms. Skewed
variables (e.g. age, index of multiple deprivation scores,
GDS scores, and SPPB scores) were transformed using
natural logarithm before hypothesis testing. Negatively
skewed variables were transformed after the scales had
been reversed. PASE data were analysed in three differ-
ent ways: complete case analysis of unambiguous data, a
“high activity” sensitivity analysis, and a “low activity”
sensitivity analysis (see details below under “Missing
data”). The “high activity” variable was shown to be posi-
tively skewed and was thus transformed on the natural
logarithmic scale for analysis. For GDS scores, there
were a substantial number of zeros, so these values were
transformed to natural log (GDS score + 1). Simple de-
scriptive statistics were used to describe the distribution
and baseline variability of all outcomes of interest for
the definitive trial. Analyses were conducted in Stata 14
(StataCorp LP, College Station, TX, USA); accelerometer
data were processed in KineSoft 3.3.75 (KineSoft, New
Brunswick, Canada).
All comparisons were analysed on an “intention to
treat” basis, i.e. the random allocations were preserved,
and individuals were analysed in the group to which they
were originally randomised.
Missing data
Missing data from enrolled participants at baseline were
obtained, where practicable, after the clinic by telephone
call. Due to the considerable volume of missing data
associated with the PASE instrument, sensitivity analyses
were conducted assuming two scenarios: a “high activity”
scenario where all missing data were assumed to relate
to the highest activity level possible on the questionnaire
and a “low activity” scenario where missing data were
assumed to relate to the lowest activity level. Multiple
imputation was not deemed appropriate given this was a
feasibility study with a small sample. Whilst multiple
imputation could have been undertaken for missing
data, we felt this was not appropriate given that this was
a small feasibility study and the PASE questionnaire was
not a primary outcome.
Results
Data have been combined for all practices used as re-
cruitment sites. Heterogeneity between practices was not
formally assessed, but visual inspection of variables such
as gender and age suggested broad homogeneity.
Recruitment
Postal invitations
Of the 1884 patients identified from GP practice lists
and sent an invitation in the post, responses were
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received from 1290 (68%). Sending a reminder increased
the response rate by 25%; there was no evidence that those
responding to the reminder differed in age (p = 0.83), gen-
der (p = 0.90), or level of deprivation (p = 0.93) compared
to those responding to the initial invitation. Only 344/1290
(27%) of the responses received were from patients inter-
ested in finding out more about the study. The major
reason expressed by the 73% of respondents who were not
interested in the study was that they were already meeting
recommended physical activity levels (55% of those not
interested in the study). Of the 344 patients interested in
the study, 311 (90%) were screened by telephone with over
a third (115/311, 37%) of patients found to be ineligible at
this stage, mainly because they were too active (see Fig. 1).
The remaining 196/311 (63%) patients were invited and
attended a clinical screening appointment at their own GP
practice. The numbers and proportions of patients invited
by post proceeding through the recruitment and screening
processes are summarised in Fig. 1.
Waiting room recruitment
Over the 6 days spent recruiting patients directly from
the practice waiting room, 37 patients were approached,
and 73% of these were not interested or reported their
own ineligibility for the study. Five patients chose to take
away an information pack, and none of these patients
returned a response slip; five were happy to provide their
contact details at the time. A further patient expressed
an interest in participating after reading an information
leaflet at the practice. Of these six patients, four were
happy to attend a screening clinic, and of these, three
(75%) were eligible and enrolled.
Enrolment
In total, 51 participants were eligible at the clinical
screening stage and all provided consent to be enrolled:
34 to the intervention arm and 17 to the control arm.
There was very strong evidence that those eligible and
enrolled in the study were older (74.1 v. 69.0 years) and
unsurprisingly had lower scores on the SPPB and a
slower walking speed compared to those not enrolled.
Of the 51 participants enrolled in the pilot trial, approxi-
mately 75% were married, and there was a high level of
home ownership (~ 80%) in both intervention and
control arms. Six percent of the enrolled participants
were non-drinkers, and this was equally balanced be-
tween intervention and control arms. Around a third of
participants felt that they could have benefitted from more
Fig. 1 Flowchart summarising outcomes of recruitment screening for those invited by post
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emotional support over the last 12months; a minority
(6%) felt that they had not had anyone to rely on for emo-
tional support over the past 12months. Data shown in
Table 3 highlight the low volumes of moderate-to-vigor-
ous physical activity (less than 5min on average per day)
and high levels of sedentary behaviour (8 h per day) by
participants at baseline. Scores on the MoCA instrument
were skewed in enrolled participants, with a median value
of 25 out of 30. The proportion of participants meeting
the criteria for depression was higher in the intervention
arm (15%) than the control arm (6%), but there was no
evidence of a difference in physical health status between
participants enrolled and those ineligible for the trial.
Adherence and retention
A CONSORT diagram is presented in Fig. 2, summarising
the numbers enrolled, receiving the minimum dose of
intervention, and providing follow-up data. One participant
died during the study, and two participants formally with-
drew from aspects of the study, one less than 48 h after en-
rolment, citing the expected burden of paperwork,
particularly the journey log as the main barrier to contin-
ued participation. During the study period, two partici-
pants from the intervention group suffered from serious
health conditions which affected delivery of the interven-
tion. Intervention sessions were temporarily suspended for
both, and their participation was reinstated once the epi-
sode resolved. Overall, 43/51 (84%) of those enrolled pro-
vided a complete set of data at the 6-month follow-up
clinic. A higher proportion (48/51; 92%) provided at least
some follow-up data, either self-reported postal data, accel-
erometry, or measures at the follow-up clinic.
Intervention dose
Most of the intervention participants (31/34, 91%)
received what was deemed the “minimum dose” of
Table 3 Key baseline characteristics of study population
Parameter Measure All enrolled Intervention Control
n (%) 51 (100%) 34 (67%) 17 (33%)
Age at screening Median (range) 74.1 (65.3–88.5) 73.6 (65.3–88.5) 74.8 (65.5–83.2)
Gender No. male (%) 30 (59%) 21 (62%) 9 (53%)
IMD Median (IQR) IMD 15.1 (4.0–33.1) 15.1 (4.6–32.6) 13.2 (6.2–23.2)
Unaided 4-m walk Mean (SD) 4 m walking speed, unaided 0.97 (0.16) 0.96 (0.13) 1.00 (0.2)
SPPB Median (IQR) SPPB score 9 (7–9) 9 (7–9) 9 (8–9)
GDS (depression) Median (IQR) GDS score (depression) 2 (0–10) 2 (0–10) 2 (1–5)
PMH Number (%) with heart disease 16 (31%) 9 (26%) 7 (41%)
Number (%) with arthritis 21 (41%) 15 (44%) 6 (35%)
BMI Median (IQR) BMI score 27.2 (22.3–35.5) 26.9 (22.3–34.2) 28.4 (26.0–33.1)
Marital status Married (%) 39 (76%) 25 (74%) 14 (82%)
Smoking status Ever smoked (%) 28 (55%) 19 (56%) 9 (53%)
Socioeconomic status Last occupation was manual (%) 21 (41%) 15 (44%) 6 (35%)
Owns own home (%) 42 (82%) 27 (79%) 15 (88%)
Detached house or bungalow (%) 13 (25%) 8 (24%) 5 (29%)
MOCA Median (IQR) MOCA score 25 (18–28) 25 (20–28) 22 (19–27)
Self-report disability Median (IQR) Lawton’s IADL score 8 (7–8) 8 (7–8) 8 (8–8)
Social support Can rely on someone for emotional support (%) 48 (94%) 32 (94%) 16 (94%)
Need more emotional support (%) 14 (29%) 9 (28%) 5 (31%)
No one to rely on to help out financially (%) 11 (22%) 7 (21%) 4 (24%)
Median (IQR) number of close friends/family 6 (2–20) 6.5 (4–14) 6 (3–10)
n (%) 50 34 16
Accelerometer-reported activity levels Daily mean (SD) hours sedentary activity 7.9 (1.1) 7.9 (1.2) 7.9 (1.1)
Daily mean (SD) hours in light activity 5.4 (1.2) 5.4 (1.2) 5.4 (1.2)
Daily median (IQR) minutes in moderate-to-vigorous
activity
4.5 (1–25) 6.5 (1–25) 2.5 (1–7)
n (%) 48 32 16
Alcohol intake Median (IQR) units/week in drinkers 3 (0–33) 4 (0–24) 3 (0.5–10.5)
SD standard deviation, IQR interquartile range, IMD index of multiple deprivation
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sessions, at least one face-to-face and five telephone ses-
sions, as per our a priori progression criteria (Table 1).
Of the three participants not receiving the minimum
dose, two had withdrawn at an early stage and one par-
ticipant died during the intervention period. The mean
(standard deviation) length of time between the first
intervention session and the final visit was 26 (2) weeks,
suggesting that the intervention sessions were delivered for
the intended period of 6months. Overall, the median
amount of time spent in contact with a participant over the
6months was 5 h, with an interquartile range from 4 to 6 h;
these data were positively skewed as a minority of partici-
pants required considerably more contact time than average.
PAFs recorded the start and end times of every contact
with a participant. The distributions of a number of
administrative and intervention telephone calls for each
participant were positively skewed, as a small number of
participants required additional input and support due
to the occurrence of serious adverse or life events. Ad-
ministrative calls were made by PAFs on an ad hoc basis,
e.g. re-arranging appointments or collecting further
details of adverse events. Table 4 shows the number and
duration of these contacts.
Feasibility of collecting outcome measures
Most outcome measures were collected comprehensively
and accurately at the baseline and follow-up clinics;
however, some survey items were associated with miss-
ing data. At baseline, only 174/200 (87%) of participants
provided PASE data that was accurate or required only
minor re-coding; at follow-up, this proportion was even
lower at 32/47 (68%). No obvious patterns were noted in
the missing PASE data; they did not appear to be related
to sensitive questions. GDS scales returned by research
nurses/HCAs after the follow-up appointments were ob-
served to have more missing/double answers than those
at baseline (6% v. 0%).
Fifty of the 51 participants (98%) wore the accelerom-
eter at baseline, with only one participant finding the re-
quirements too demanding. All accelerometers sent out
to participants before their follow-up appointments were
returned, with 44/48 (92%) of participants wearing one.
Data retrieved from the accelerometers revealed that of
the accelerometers returned at baseline 48/50 (96%),
participants had worn it for at least one valid day, as
Fig. 2 CONSORT diagram
Table 4 Contacts with PAF
Average number
(IQR/SD)
Mean duration (SD),
minutes
Administrative
telephone calls
4 (1–8) 4 (2)
Telephone sessions 8 (7–11) 18 (4)
Face-to-face session 3 (0.5) 45 (8)
IQR interquartile range, SD standard deviation
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detected by motion counts. At follow-up, the proportion
was similar at 43/44 (91%). At baseline 42/50 (84%),
participants returning a worn accelerometer had worn it
for at least five valid days; at follow-up, this proportion
remained high at 39/44 (89%).
Healthcare utilisation data were available for 46 partic-
ipants at baseline and 39 participants at follow-up
(Table 5); rates per person-year were calculated. Hospital
and urgent care attendances, including A&E, out-of-
hours GP services, and rapid access chest pain clinics,
were rare, and the small sample size resulted in large
confidence intervals.
Additional file 2: Table S1 shows the point estimates
and variability for primary and secondary outcomes, as
likely to be primary outcomes in a definitive trial. One
participant in the control arm suffered from a stroke
and was unable to attempt the walk test at follow-up;
hence, n = 15 for the follow-up. Additional file 2: Table
S1 also contains the effect estimates (mean difference or
odds ratio), confidence interval, and p value for each
outcome, calculated in fully adjusted regression models.
Whilst there appears to be moderately strong evidence
against the null hypothesis for several of these outcomes,
the study was not powered to detect such differences,
and therefore, these should not be considered as
evidence of effectiveness and the results should be
treated with caution.
Variability estimates for key outcomes
A putative sample size calculation was performed to es-
timate the numbers required for a definitive trial, based
on an assumed primary outcome of walking speed
(standard deviation of walking speed of 0.2, as shown in
Additional file 2: Table S1), an alpha level of 0.05, and a
beta of 0.90. The minimal clinically important difference
(MCID) was obtained from work published by the LIFE
study team, who used data from over 400 participants to
identify the MCID for walk speed using a five-point
self-reported assessment of mobility ability as anchors.
An increase of between 0.03 and 0.05 m/s in 4-m walk-
ing speed was deemed to be the minimum change asso-
ciated with clinically significant improvement [29].
Sample sizes were calculated for each end of the range
of MCIDs (see Table 6).
In this pilot study, 48/51 (94%) of participants who
were enrolled provided some level of follow-up data,
so sample size calculations should be adjusted for an
assumed loss to follow-up rate of 10%, and if a de-
finitive RCT was undertaken in primary care, it would
also be necessary to consider adjusting the sample
size to account for clustering by practice and
household.
Feasibility criteria
The criteria pertaining to the feasibility elements of the
pilot are shown in Table 1, and Table 7 shows a sum-
mary of whether and how the criteria were met based on
our findings presented in this paper.
Discussion
The study reported in this paper was designed to assess
the feasibility of running a definitive RCT of the PAF
intervention, designed to improve physical function in
older adults, in a primary care setting. Findings presented
here reveal that our a priori progression criteria for the
trial processes have been met, and therefore, it is feasible
to deliver a trial of this nature. Postal recruitment was
effective and feasible to deliver at scale, and the proce-
dures for two-stage screening were successful in identify-
ing a sample of patients meeting the eligibility criteria.
Most outcome measures were collected successfully at
baseline and follow-up; accelerometers were well toler-
ated, and this method is viable for collecting objective
measurement of physical activity.
Strengths
By asking PAFs to complete diaries, we could assess
the feasibility of collecting accurate data on the cost
of the intervention; the completeness of these diaries
and the low rates of missing data in the EQ5D and
ICECAP-O survey items used to calculate QALYs
make economic evaluation a feasible component of a
definitive trial. A further strength of the PAF diaries
is that they enabled us to understand whether
Table 5 Rates of healthcare utilisation
Baseline Follow-up
Intervention (n = 30) Control (n = 16) Intervention (n = 24) Control (n = 15)
Rate/py 95% CI Rate/py 95% CI Rate/py 95% CI Rate/py 95% CI
GP appointments 5.02 4.28, 5.89 4.49 3.56, 5.65 3.48 2.13, 5.68 3.46 1.96, 6.09
Hospital admissions 1.53 1.15, 2.04 1.81 1.26, 2.60 2.17 1.17, 4.04 1.73 0.78, 3.85
Outpatient appointments 0.13 0.05, 0.35 0 na 0.22 0.031, 1.5 0 na
Urgent Care 0.70 0.46, 1.07 0.50 0.25, 1.00 0.43 0.11, 1.7 0.29 0.04, 2.1
py person-year, CI confidence interval
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participants were receiving the correct “dose” of
intervention and to identify and explore the reasons
behind a very small number of participants receiving
very high levels of contact (data to be published sep-
arately). Collection of data from the primary care
record on healthcare utilisation was also shown to be
feasible, though further work should validate this
data source and explore methods for automation (e.g.
using linked datasets) which would reduce time bur-
den and user error.
Recruitment from six different GP practices and
involvement of more than one PAF in delivery of the
intervention are further strengths, as both highlight the
generalisability of setting and agent of change.
Moreover, the pilot RCT was sufficiently large as to
enable estimation of the samples size that would be
required to conduct an adequately powered definitive
trial using a primary outcome that we have tested and
shown to be feasible.
Lessons learned
Whilst our findings are positive, there are some useful
learning points from this pilot study which should be
Table 7 Assessment of feasibility criteria
Criteria for proceeding to
a definitive trial
Assessment Criterion
fulfilled?
Evidence
An acceptable proportion of
individuals respond to recruitment
invitations.
Recruitment records show an initial response
rate of > 10% to postal invitation and/or > 25%
to primary care practitioner invitation or waiting room
recruitment. The three methods will be compared.
Yes Response to postal invitation
was high at 68% overall and
27% of responders interested
and self-reporting as eligible
for the study.
An acceptable proportion of
individuals responding to
recruitment invitations are
eligible to participate.
Screening records show a screen-failure rate
of < 80%.
Yes The screen-failure rate at
clinical screening was 74%.
Attrition from the exploratory
pilot trial is low.
Trial records show that the proportion of enrolled
participants “lost to follow-up” at 6 months is
< 20%, excluding deaths and long-term care or
hospitalisation.
Yes Excluding deaths and formal
withdrawals, only one
participant was lost to follow-
up at 6 months (2%).
PAF intervention attracts high
rates of participation from eligible
adults.
Trial records indicate that adherence to the
intervention is high; ≥ 65% of intervention
participants participate in at least one
face-to-face and five telephone sessions.
Yes Adherence was very high; 91%
of intervention participants
received at least one face-to-
face and five telephone
sessions.
PAF can engage individuals from a
range of socio-economic localities.
Participants are recruited from primary care practices
in wards with high deprivation scores and low
deprivation scores.
Yes Practices and participants from
a variety of sociodemographic
backgrounds were involved in
the study.
PAF delivery costs can be
recorded in a way that enables
cost-effectiveness analysis.
Systems developed in the exploratory trial can be
used to monitor the costs of a definitive RCT.
Yes Collection of data on PAF
contact time is feasible and
could be employed alongside
standard trial methods for
monitoring costs.
Methods for measuring primary
and secondary outcomes and
mediator variables are feasible and
acceptable.
Process evaluation findings and completed
questionnaires suggest that self-report and
objective measures were comprehensible
and acceptable to > 80% of participants.
Yes—with
modification
(PASE questionnaire)
Measurement of outcomes
was acceptable and largely
feasible. However, the pilot
study revealed issues with
some self-report instruments
and ascertainment of these
outcomes would need to be
modified in any potential future
definitive trial.
The sample size required for
an adequately powered trial
is achievable.
Measurement variability of the primary
outcome, recruitment rates, and expected
attrition are consistent with a sample size
that can be achieved within a reasonable time.
Yes Sample size calculations under a
range of parameters all suggest a
definitive trial is achievable.
Table 6 Sample size requirements according to different MCIDs
and power levels for walking speed
MCID on 4MWT
MCID 0.03 m/s 0.05 m/s
Power 80% 351 128
Power 90% 469 171
MCID minimal clinically important difference, m/s metres per second
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considered when designing a definitive trial. Waiting
room recruitment was not deemed to be an effective
strategy in this population, despite reports by others of
its effectiveness [30]. This may be due to the age of the
population targeted, who are likely to have more signifi-
cant health concerns than younger adults and therefore
may not be as receptive to discussing research participa-
tion whilst awaiting a GP consultation.
Whilst procedures for screening were implemented with
few problems overall, the screen-positive rate of 26% is
low. The time taken to screen potential participants was
therefore greater than anticipated, so the recruitment
closed before reaching the desired 60 participants; how-
ever, as this was an unpowered pilot study, the total sam-
ple size was not critical to the study. Improved methods
for selecting patients to screen would be required to make
this stage more manageable and cost-effective in a defini-
tive trial. Recruitment to this pilot trial by postal invitation
involved 1884 invitations which were sent to recruit 48
participants, an overall recruitment rate of 3%. Our sam-
ple size calculation suggests that a final sample of between
128 and 469 participants would be required for a definitive
trial. Employing the same recruitment approach as in this
pilot study would therefore require postal invitations to be
sent to between 4267 and 15,633 people and between 533
and 1954 people to be clinically screened in order to meet
the sample requirement. As this is an inefficient approach
to recruitment, an alternative approach will be required.
Potential solutions to improve recruitment efficiency in-
clude better targeting of invitations to patients at risk of
disability, e.g. through identifying read codes which are
predictive of functional ability, by raising the age threshold
to 70 or 75 years, and by providing clearer and more in-
formative eligibility descriptions in the recruitment mate-
rials. Given the large proportion of responses from
patients who were self-reporting ineligibility (55% of pos-
tal reply slips and 27% of those screened by telephone), in-
creasing the specificity of self-reported eligibility would
reduce the volume of responses from patients who had a
high level of physical function at baseline. It has been
shown that walking speed alone can represent nearly all of
the predictive value of the SPPB [31], is quick and low
cost, and may be done outside of a clinical setting. There
has also been some work to validate self-reported per-
formance on tests of physical performance, using a “virtual
SPPB” test [32]. It would be feasible to design an app that
participants downloaded and allowed them to test their
walking speed with automatic notification to the study
team as to whether they were eligible or not. Whether
such an approach is acceptable and cost-effective in
recruiting this population is unknown but testable. Simpli-
fying and streamlining the approach to identifying the eli-
gible population would reduce the overall workload and
cost of recruitment.
Most of the data were collected successfully as nomi-
nated primary and secondary outcomes for a definitive
trial; however, the PASE tool, used to measure
self-reported physical activity, had high levels of miss-
ing data. Given the low correlation between
self-reported and objectively measured physical activity
[33], the role of self-reported physical activity in trials
with older adults at all is questionable. Furthermore,
self-reported physical activity measures are dependent
upon high-level cognitive processes to accurately recall
details and timings about activities in the past; with
older adults, misclassification due to mild cognitive
impairment may be increasingly likely. Careful consid-
eration should be given to whether self-reported phys-
ical activity would add any value to a definitive trial.
Conclusions
We conclude that it is feasible and practical to deliver
an RCT of a one-to-one behavioural physical activity
intervention like the PAF intervention described here,
in a population of older adults at risk of disability. To
improve the efficiency of the recruitment process,
greater specificity in identifying the target population
is required and we have suggested several approaches
to doing this. It is generally agreed that tackling the
burden of age-associated dependency will require a
multi-level approach including effective treatment of
chronic diseases, reduction in risk factors for cardio-
and cerebrovascular disease (e.g. hypertension, hyper-
cholesterolemia, tobacco use), efficient care packages,
reduced reliance on care homes, and encouraging and
supporting older adults to remain economically active
for longer [34], where appropriate. Nevertheless, this
pilot trial shows that it would be feasible to evaluate
one approach to risk factor reduction, and if an inter-
vention such as PAF can show similar effects to the
LIFE study, but at lower cost, then this has the poten-
tial to have a considerable impact at a population level.
Additional files
Additional file 1: Figure S1. Screening flowchart. (PNG 78 kb)
Additional file 2: Table S1. Complete data on estimates and regression
outputs for primary and secondary outcomes. (DOCX 27 kb)
Acknowledgements
The work was undertaken with the support of The Centre for the Development and
Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a
UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart
Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-
28-0005), Medical Research Council, the Welsh Assembly Government and the
Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research
Collaboration, is gratefully acknowledged.
The study is sponsored by the University of Bristol. The funder and sponsor
had no role in the study design; collection, management, analysis, and
Morgan et al. Pilot and Feasibility Studies            (2019) 5:40 Page 11 of 13
interpretation of data; writing of the report; and the decision to submit the
report for publication.
Funding
This research was funded by the National Institute of Research (NIHR) (DRF-
2012-05-123). The views expressed in this publication are those of the
authors and not necessarily those of the NHS, the National Institute for
Health Research or the Department of Health.and Social Care (DHCS).
Service support costs and excess treatment costs have been provided by
Western Clinical Local Research Network and Avon Primary Care Research
Collaborative.
Availability of data and materials
Please contact the corresponding author with requests. Ethical approval and
associated requirements may prevent the sharing of study data.
Authors’ contributions
All authors contributed to the design of the trial and its procedures. GSM was
the principal investigator and conducted the data collection and analysis. AH
contributed to the development of the intervention materials and the training
and supervision of the facilitators. YBS, RC, and AH acted as PhD supervisors for
GSM for the duration of the project. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Ethical approval was granted by the Yorkshire & the Humber - Humber
Bridge National Research Ethics Service (NRES) Committee (ref 13/YH/0319).
Consent was obtained from all study participants at the point of enrolment.
Consent for publication
Not applicable; no individual-level data are presented in the article.
Competing interests
Rona Campbell is a Director of DECIPHer Impact Limited, a not-for-profit
company, wholly owned by the Universities of Bristol and Cardiff, which
exists to licence and support the implementation of evidence-based public
health interventions. The remaining authors declare that they have no
competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Population Health Sciences, Bristol Medical School, University of Bristol,
Bristol, UK. 2School of Policy Studies, University of Bristol, Bristol, UK.
Received: 17 August 2018 Accepted: 6 February 2019
References
1. Office of National Statistics. Overview of the UK population: March
2017. 2017.
2. Pahor M, Guralnik JM, Ambrosius WT. Effect of structured physical activity
on prevention of major mobility disability in older adults: the LIFE study
randomized clinical trial. JAMA. 2014;311(23):2387–96.
3. Chief Medical Officers of England, Wales, and Northern Ireland. Start active,
stay active: a report on physical activity for health from the four home
countries’ Chief Medical Officers. 2011.
4. NHS Digital. Health Survey for England 2016. Physical activity in adults.
5. Townsend N, Wickramasinghe K, Williams J, Bhatnagar P, Rayner M. Physical
activity statistics 2015. London: British Heart Foundation; 2015.
6. Haase AM, Taylor AH, Fox KR, Thorp H, Lewis G. Rationale and development
of the physical activity counselling intervention for a pragmatic TRial of
Exercise and Depression in the UK (TREAD-UK). Ment Health Phys Act. 2010;
3(2):85–91.
7. Chalder M, Wiles N, Campbell J, Hollinghurst S, Searle A. A pragmatic
randomised controlled trial to evaluate the cost-effectiveness of a physical
activity intervention as a treatment for depression: the treating depression
with physical activity (TREAD) trial. Health Technol Assess. 2012;16(10):164.
8. Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Haase AM, Taylor AH, et al.
Facilitated physical activity as a treatment for depressed adults: randomised
controlled trial. Br Med J. 2012;344:e2758
9. Morgan GS, Haase AM, Campbell R, Ben-Shlomo Y. Physical ACtivity
facilitation for Elders (PACE): study protocol for a randomised controlled
trial. Trials. 2015;16(1):91.
10. Arain M, Campbell M, Cooper C, Lancaster G. What is a pilot or feasibility
study? A review of current practice and editorial policy. BMC Med Res
Methodol. 2010;10(1):67.
11. Rolland YM, Cesari M, Miller ME, Penninx BW, Atkinson HH, Pahor M.
Reliability of the 400-M usual-pace walk test as an assessment of mobility
limitation in older adults. J Am Geriatr Soc. 2004;52(6):972–6.
12. Rejeski WJ, Fielding RA, Blair SN, Guralnik JM, Gill TM, Hadley EC, et al. The
lifestyle interventions and independence for elders (LIFE) pilot study: design
and methods. Contemp Clin Trials. 2005;26(2):141–54.
13. Ostir G, Volpato S, Fried L, Chaves P, Guralnik J. Reliability and sensitivity to
change assessed for a summary measure of lower body function. J Clin
Epidemiol. 2002;55(9):916–21.
14. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et
al. A short physical performance battery assessing lower extremity function:
association with self-reported disability and prediction of mortality and
nursing home admission. J Gerontol. 1994;49(2):M85.
15. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-
extremity function in persons over the age of 70 years as a predictor of
subsequent disability. N Engl J Med. 1995;332(9):556–62.
16. Gawel J, Vengrow D, Collins J, Brown S, Buchanan A, Cook C. The Short
Physical Performance Battery as a predictor for long term disability or
institutionalization in the community dwelling population aged 65 years old
or older. Phys Ther Rev. 2012;17(1):37–44.
17. Dumville JC, Hahn S, Miles JNV, Torgerson DJ. The use of unequal randomisation
ratios in clinical trials: A review. Contemp Clin Trials. 2006;27(1):1–12.
18. Deci E, Ryan R. Self-determination theory: a macrotheory of human
motivation, development, and health. Can Psychol. 2008;49:182–5.
19. Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective
techniques in healthy eating and physical activity interventions: a meta-
regression. Health Psychol. 2009;28(6):690.
20. Davis M, Fox K. Physical activity patterns assessed by accelerometry in older
people. Eur J Appl Physiol. 2007;100(5):581–9.
21. NIH Toolbox Grip Strength Test. Available from: hthttp://www.
healthmeasures.net/index.php?option=com_instruments&view=
measure&id=260&Itemid=992 . Accessed 16 Feb 2019.
22. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence
and development of a shorter version. Clin Gerontol. 1986;5(1-2):165-73.
23. Washburn RA, Smitzh KW, Jette AM, Janney CA. The Physical Activity Scale
for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;
46(2):153–62.
24. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I,
et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
25. Lawton, MP and Brody EM. Assessment of older people: self-maintaining
and instrumental activities of daily living. The Gerontologist. 1969;9(3, Part
1):179-86.
26. Couzner L, Crotty M, Norman R, Ratcliffe J. A comparison of the EQ-5D-3L
and ICECAP-O in an older post-acute patient population relative to the
general population. Appl Health Econ Health Policy. 2013;11(4):415–25.
27. Makai P, Koopmanschap MA, Brouwer WBF, AAP N. A validation of the
ICECAP-O in a population of post-hospitalized older people in the
Netherlands. Health Qual Life Outcomes. 2013;11:57.
28. Davis JC, Liu-Ambrose T, Richardson CG, Bryan S. A comparison of the
ICECAP-O with EQ-5D in a falls prevention clinical setting: are they
complements or substitutes? Qual Life Res. 2013;22(5):969–77.
29. Kwon S, Perera S, Pahor M, Katula J, King A, Groessl E, et al. What is a
meaningful change in physical performance? Findings from a clinical trial in
older adults (the LIFE-P study). JNHA-The Journal of Nutrition, Health Aging.
2009;13(6):538–44.
30. Hillsdon M. Rates of recruitment from systematic and opportunistic
methods: preliminary results from the DDELPHI study. Trials. 2011;
12(Suppl 1):A112.
31. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, et al.
Lower extremity function and subsequent disability: consistency across
studies, predictive models, and value of gait speed alone compared with
Morgan et al. Pilot and Feasibility Studies            (2019) 5:40 Page 12 of 13
the Short Physical Performance Battery. J Gerontol Ser A Biol Med Sci. 2000;
55(4):M221–M31.
32. Marsh AP, Wrights AP, Haakonssen EH, Dobrosielski MA, Chmelo EA, Barnard
RT, et al. The virtual Short Physical Performance Battery. J Gerontol Ser A
Biol Med Sci. 2015;70(10):1233–41.
33. Harris TJ, Owen CG, Victor CR, Adams R, Ekelund U, Cook DG. A comparison
of questionnaire, accelerometer, and pedometer: measures in older people.
Med Sci Sports Exerc. 2009;41(7):1392–402.
34. Bloom DE, Chatterji S, Kowal P, Lloyd-Sherlock P, McKee M, Rechel B, et al.
Macroeconomic implications of population ageing and selected policy
responses. Lancet. 2015;385(9968):649–57.
Morgan et al. Pilot and Feasibility Studies            (2019) 5:40 Page 13 of 13
